Non-Biological Complex Drugs The Science and the Regulatory Landscape /

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufactu...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Crommelin, Daan J.A (Επιμελητής έκδοσης), de Vlieger, Jon S. B. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Σειρά:AAPS Advances in the Pharmaceutical Sciences Series, 20
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Introduction: Defining the position of Non-Biological Complex Drugs
  • Polymeric micelles
  • Liposomes: the science and the regulatory landscape
  • Glatiramoids
  • Iron carbohydrate complexes: characteristics and regulatory challenges
  • Drug Nanocrystals
  • Analytical methods for determining the size (distribution) in parenternal dispersions
  • NBCD Pharmacokinetics and Bioanalytical Methods to Measure Drug Release
  • Low Molecular Weight Heparins, Biological Drugs close to Non-Biological Complex Drugs
  • Nanoparticle Albumin-Bound Anticancer Agents
  • The EU regulatory landscape of Non-Biological Complex Drugs
  • What did we learn? What can we expect in the future? Concluding remarks and outstanding issues.